Does PANOBINOSTAT Cause Malignant neoplasm progression? 166 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Malignant neoplasm progression have been filed in association with PANOBINOSTAT. This represents 9.1% of all adverse event reports for PANOBINOSTAT.
166
Reports of Malignant neoplasm progression with PANOBINOSTAT
9.1%
of all PANOBINOSTAT reports
104
Deaths
61
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PANOBINOSTAT?
Of the 166 reports, 104 (62.7%) resulted in death, 61 (36.7%) required hospitalization, and 22 (13.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANOBINOSTAT. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does PANOBINOSTAT Cause?
Diarrhoea (368)
Plasma cell myeloma (279)
Platelet count decreased (192)
Death (190)
Fatigue (162)
Nausea (154)
Thrombocytopenia (141)
Off label use (112)
Vomiting (109)
Drug ineffective (105)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PANOBINOSTAT Alternatives Have Lower Malignant neoplasm progression Risk?
PANOBINOSTAT vs PANTOPRAZOLE
PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS
PANOBINOSTAT vs PANTOTHENIC ACID
PANOBINOSTAT vs PAPAVERINE
PANOBINOSTAT vs PARACETAMOL